Core Viewpoint - CME Group shares have increased by approximately 7.1% since the last earnings report, outperforming the S&P 500, raising questions about the sustainability of this positive trend leading up to the next earnings release [1] Estimates Movement - Consensus estimates for CME Group have trended upward over the past month, with a shift of 5.97% in estimates due to recent changes [2] VGM Scores - CME Group currently holds a subpar Growth Score of D and a Momentum Score of F, with a Value Score also graded at D, placing it in the bottom 40% for this investment strategy; the overall aggregate VGM Score is F [3] Outlook - The upward trend in estimates is promising, and CME Group holds a Zacks Rank of 2 (Buy), indicating expectations for above-average returns in the coming months [4]
CME (CME) Up 7.1% Since Last Earnings Report: Can It Continue?